Found 3 hits for monomerid = 347503 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347503
(US9790180, ID 035)Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)Cc2c[nH]c3ccccc23)nc1)-c1ccccc1 Show InChI InChI=1S/C32H31N7O2/c33-27-11-10-22(21-6-2-1-3-7-21)16-29(27)38-31(41)24-19-35-32(36-20-24)37-25-12-14-39(15-13-25)30(40)17-23-18-34-28-9-5-4-8-26(23)28/h1-11,16,18-20,25,34H,12-15,17,33H2,(H,38,41)(H,35,36,37) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 3
(Homo sapiens (Human)) | BDBM347503
(US9790180, ID 035)Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)Cc2c[nH]c3ccccc23)nc1)-c1ccccc1 Show InChI InChI=1S/C32H31N7O2/c33-27-11-10-22(21-6-2-1-3-7-21)16-29(27)38-31(41)24-19-35-32(36-20-24)37-25-12-14-39(15-13-25)30(40)17-23-18-34-28-9-5-4-8-26(23)28/h1-11,16,18-20,25,34H,12-15,17,33H2,(H,38,41)(H,35,36,37) | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347503
(US9790180, ID 035)Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)Cc2c[nH]c3ccccc23)nc1)-c1ccccc1 Show InChI InChI=1S/C32H31N7O2/c33-27-11-10-22(21-6-2-1-3-7-21)16-29(27)38-31(41)24-19-35-32(36-20-24)37-25-12-14-39(15-13-25)30(40)17-23-18-34-28-9-5-4-8-26(23)28/h1-11,16,18-20,25,34H,12-15,17,33H2,(H,38,41)(H,35,36,37) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 196 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this
Ligand-Target Pair | |
Search and Browse
